America Great Health (AAGH)

OTCMKTS · Delayed Price · Currency is USD

0.0001

0.00 (0.00%)

At close: Jul 6, 2026

-66.67% (1Y)

Market Cap	2.12M -96.5%
Revenue (ttm)	393.34K -6.5%
Net Income	646.73K
EPS	0.00
Shares Out	21.20B
PE Ratio	3.33
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	97,100
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.000001 - 0.0010
Beta	-11.17
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 18, 2026

About America Great Health

America Great Health operates as a biotechnology company in the United States. The company focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and re-generational medicine and supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California. [Read more]

Industry Biotechnology

Sector Healthcare

CEO Mike Wang

Employees 5

Stock Exchange OTCMKTS

Ticker Symbol AAGH

Full Company Profile

Financial Performance

In fiscal year 2025, America Great Health's revenue was $391,743, an increase of 32.94% compared to the previous year's $294,670. Losses were -$719,119, -41.08% less than in 2024.

Financial Statements